Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
24733 | 303 | 48.4 | 91% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
10 | 3 | IMMUNOLOGY//JOURNAL OF IMMUNOLOGY//IMMUNOL | 134299 |
140 | 2 | IMMUNOTHERAPY//DENDRITIC CELLS//CANCER IMMUNOLOGY IMMUNOTHERAPY | 23462 |
24733 | 1 | TUMOR IMMUN TOLERANCE SECT//SV40 T ANTIGEN TRANSGENIC MICE//CCDC134 | 303 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TUMOR IMMUN TOLERANCE SECT | address | 229032 | 2% | 45% | 5 |
2 | SV40 T ANTIGEN TRANSGENIC MICE | authKW | 201553 | 1% | 100% | 2 |
3 | CCDC134 | authKW | 134367 | 1% | 67% | 2 |
4 | 12TH INTERNATIONAL DC SYMPOSIUM | authKW | 100776 | 0% | 100% | 1 |
5 | ALPHA AMYLASE EXPRESSION IN SALIVARY GLANDS AND RIBS | authKW | 100776 | 0% | 100% | 1 |
6 | APOPTOSIS AND PROLIFERATION RATES | authKW | 100776 | 0% | 100% | 1 |
7 | ASSOCIE 9 | address | 100776 | 0% | 100% | 1 |
8 | ASSOCIE COM PARIS LIGUE CONTRE CANC 11 | address | 100776 | 0% | 100% | 1 |
9 | AUSTRALIAN MESOTHELIOMA TUMOUR BANK | address | 100776 | 0% | 100% | 1 |
10 | BETH ISRAEL DEACONESS MED UROL | address | 100776 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Immunology | 4862 | 60% | 0% | 182 |
2 | Oncology | 933 | 30% | 0% | 90 |
3 | Medicine, Research & Experimental | 469 | 16% | 0% | 47 |
4 | Cell Biology | 87 | 11% | 0% | 32 |
5 | Virology | 41 | 3% | 0% | 10 |
6 | Gastroenterology & Hepatology | 2 | 2% | 0% | 5 |
7 | Genetics & Heredity | 2 | 3% | 0% | 8 |
8 | Hematology | 2 | 2% | 0% | 5 |
9 | Integrative & Complementary Medicine | 1 | 0% | 0% | 1 |
10 | Biotechnology & Applied Microbiology | 0 | 2% | 0% | 6 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TUMOR IMMUN TOLERANCE SECT | 229032 | 2% | 45% | 5 |
2 | ASSOCIE 9 | 100776 | 0% | 100% | 1 |
3 | ASSOCIE COM PARIS LIGUE CONTRE CANC 11 | 100776 | 0% | 100% | 1 |
4 | AUSTRALIAN MESOTHELIOMA TUMOUR BANK | 100776 | 0% | 100% | 1 |
5 | BETH ISRAEL DEACONESS MED UROL | 100776 | 0% | 100% | 1 |
6 | CANC INFLAMMAT PROGRAMCCR | 100776 | 0% | 100% | 1 |
7 | CELLULAR THER Y STEM CELL SIGNALING | 100776 | 0% | 100% | 1 |
8 | CLIN HUMAN IMMUNOL CHI | 100776 | 0% | 100% | 1 |
9 | CLIN MED SCI TRADIT CHINESE MED | 100776 | 0% | 100% | 1 |
10 | COCHIN GENET MOLINSERMU129 | 100776 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ONCOIMMUNOLOGY | 8530 | 3% | 1% | 9 |
2 | JOURNAL OF IMMUNOLOGY | 7749 | 21% | 0% | 64 |
3 | JOURNAL OF EXPERIMENTAL MEDICINE | 2955 | 6% | 0% | 19 |
4 | CANCER IMMUNOLOGY RESEARCH | 2014 | 1% | 1% | 3 |
5 | IMMUNOLOGY AND CELL BIOLOGY | 1574 | 2% | 0% | 6 |
6 | JOURNAL OF IMMUNOTHERAPY | 1490 | 2% | 0% | 5 |
7 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 1474 | 3% | 0% | 8 |
8 | CANCER RESEARCH | 1344 | 8% | 0% | 23 |
9 | CURRENT OPINION IN IMMUNOLOGY | 1309 | 2% | 0% | 6 |
10 | CANCER CELL | 1049 | 1% | 0% | 4 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SV40 T ANTIGEN TRANSGENIC MICE | 201553 | 1% | 100% | 2 | Search SV40+T+ANTIGEN+TRANSGENIC+MICE | Search SV40+T+ANTIGEN+TRANSGENIC+MICE |
2 | CCDC134 | 134367 | 1% | 67% | 2 | Search CCDC134 | Search CCDC134 |
3 | 12TH INTERNATIONAL DC SYMPOSIUM | 100776 | 0% | 100% | 1 | Search 12TH+INTERNATIONAL+DC+SYMPOSIUM | Search 12TH+INTERNATIONAL+DC+SYMPOSIUM |
4 | ALPHA AMYLASE EXPRESSION IN SALIVARY GLANDS AND RIBS | 100776 | 0% | 100% | 1 | Search ALPHA+AMYLASE+EXPRESSION+IN+SALIVARY+GLANDS+AND+RIBS | Search ALPHA+AMYLASE+EXPRESSION+IN+SALIVARY+GLANDS+AND+RIBS |
5 | APOPTOSIS AND PROLIFERATION RATES | 100776 | 0% | 100% | 1 | Search APOPTOSIS+AND+PROLIFERATION+RATES | Search APOPTOSIS+AND+PROLIFERATION+RATES |
6 | CCL 16 | 100776 | 0% | 100% | 1 | Search CCL+16 | Search CCL+16 |
7 | CLONE 4 | 100776 | 0% | 100% | 1 | Search CLONE+4 | Search CLONE+4 |
8 | CTL ESCAPE VARIANT | 100776 | 0% | 100% | 1 | Search CTL+ESCAPE+VARIANT | Search CTL+ESCAPE+VARIANT |
9 | DAEGU EXCO | 100776 | 0% | 100% | 1 | Search DAEGU+EXCO | Search DAEGU+EXCO |
10 | DC2012 | 100776 | 0% | 100% | 1 | Search DC2012 | Search DC2012 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BRIESEMEISTER, D , SOMMERMEYER, D , LODDENKEMPER, C , LOEW, R , UCKERT, W , BLANKENSTEIN, T , KAMMERTOENS, T , (2011) TUMOR REJECTION BY LOCAL INTERFERON GAMMA INDUCTION IN ESTABLISHED TUMORS IS ASSOCIATED WITH BLOOD VESSEL DESTRUCTION AND NECROSIS.INTERNATIONAL JOURNAL OF CANCER. VOL. 128. ISSUE 2. P. 371 -378 | 16 | 62% | 8 |
2 | LISTOPAD, JJ , KAMMERTOENS, T , ANDERS, K , SILKENSTEDT, B , WILLIMSKY, G , SCHMIDT, K , KUEHL, AA , LODDENKEMPER, C , BLANKENSTEIN, T , (2013) FAS EXPRESSION BY TUMOR STROMA IS REQUIRED FOR CANCER ERADICATION.PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. VOL. 110. ISSUE 6. P. 2276-2281 | 15 | 47% | 16 |
3 | GANSS, R , ARNOLD, B , HAMMERLING, GJ , (2004) OVERCOMING TUMOR-INTRINSIC RESISTANCE TO IMMUNE EFFECTOR FUNCTION.EUROPEAN JOURNAL OF IMMUNOLOGY. VOL. 34. ISSUE 10. P. 2635-2641 | 22 | 40% | 45 |
4 | CONTASSOT, E , PREYNAT-SEAUVE, O , FRENCH, L , HUARD, B , (2009) LYMPH NODE TUMOR METASTASES: MORE SUSCEPTIBLE THAN PRIMARY TUMORS TO CD8(+) T-CELL IMMUNE DESTRUCTION.TRENDS IN IMMUNOLOGY. VOL. 30. ISSUE 12. P. 569 -573 | 17 | 46% | 5 |
5 | OTAHAL, P , SCHELL, TD , HUTCHINSON, SC , KNOWLES, BB , TEVETHIA, SS , (2006) EARLY IMMUNIZATION INDUCES PERSISTENT TUMOR-INFILTRATING CD8(+) T CELLS AGAINST AN IMMUNODOMINANT EPITOPE AND PROMOTES LIFELONG CONTROL OF PANCREATIC TUMOR PROGRESSION IN SV40 TUMOR ANTIGEN TRANSGENIC MICE.JOURNAL OF IMMUNOLOGY. VOL. 177. ISSUE 5. P. 3089-3099 | 23 | 35% | 14 |
6 | ANDERS, K , BUSCHOW, C , HERRMANN, A , MILOJKOVIC, A , LODDENKEMPER, C , KAMMERTOENS, T , DANIEL, P , YU, H , CHARO, J , BLANKENSTEIN, T , (2011) ONCOGENE-TARGETING T CELLS REJECT LARGE TUMORS WHILE ONCOGENE INACTIVATION SELECTS ESCAPE VARIANTS IN MOUSE MODELS OF CANCER.CANCER CELL. VOL. 20. ISSUE 6. P. 755-767 | 15 | 36% | 12 |
7 | BLANKENSTEIN, T , (2005) THE ROLE OF TUMOR STROMA IN THE INTERACTION BETWEEN TUMOR AND IMMUNE SYSTEM.CURRENT OPINION IN IMMUNOLOGY. VOL. 17. ISSUE 2. P. 180-186 | 17 | 32% | 126 |
8 | DUPAGE, M , CHEUNG, AF , MAZUMDAR, C , WINSLOW, MM , BRONSON, R , SCHMIDT, LM , CROWLEY, D , CHEN, JZ , JACKS, T , (2011) ENDOGENOUS T CELL RESPONSES TO ANTIGENS EXPRESSED IN LUNG ADENOCARCINOMAS DELAY MALIGNANT TUMOR PROGRESSION.CANCER CELL. VOL. 19. ISSUE 1. P. 72-85 | 15 | 29% | 64 |
9 | TEXTOR, A , SCHMIDT, K , KLOETZEL, PM , WEISSBRICH, B , PEREZ, C , CHARO, J , ANDERS, K , SIDNEY, J , SETTE, A , SCHUMACHER, TNM , ET AL (2016) PREVENTING TUMOR ESCAPE BY TARGETING A POST-PROTEASOMAL TRIMMING INDEPENDENT EPITOPE.JOURNAL OF EXPERIMENTAL MEDICINE. VOL. 213. ISSUE 11. P. 2333 -2348 | 16 | 27% | 1 |
10 | KAMMERTOENS, T , SCHULER, T , BLANKENSTEIN, T , (2005) IMMUNOTHERAPY: TARGET THE STROMA TO HIT THE TUMOR.TRENDS IN MOLECULAR MEDICINE. VOL. 11. ISSUE 5. P. 225-231 | 19 | 30% | 51 |
Classes with closest relation at Level 1 |